Evidence map›Paper›PMID 37110928›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Green Synthesis: The Antibacterial and Photocatalytic Potential of Silver Nanoparticles Using Extract of

Iqra Rehman, Humaira Yasmeen Gondal, Roshan Zamir, Sami A Al-Hussain, Fozia Batool, Ali Irfan, Sobia Noreen, Taleeha Roheen, Muhammad Nisar, Magdi E A Zaki

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. RSC advances · 2026
    Article
  2. Article
  3. Article
  4. Biogenic synthesis of silver nanoparticles usingBiotechnology notes (Amsterdam, Netherlands) · 2025
    Article
  5. Green Silver Nanoparticles: An Antibacterial Mechanism.Antibiotics (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Review
  8. Green Synthesis of Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Iqra RehmanInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Humaira Yasmeen GondalInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Roshan ZamirInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Sami A Al-HussainDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13623, Saudi Arabia.
Fozia BatoolInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0000-0001-8023-7558
Ali IrfanDepartment of Chemistry, Government College University Faisalabad, Faisalabad 38000, Pakistan.ORCID 0000-0002-8977-3303
Sobia NoreenInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0000-0002-0815-2223
Taleeha RoheenInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Muhammad NisarInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Magdi E A ZakiDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13623, Saudi Arabia.ORCID 0000-0002-5643-9202
University of Sargodha · PKImam Mohammad ibn Saud Islamic University · SAGovernment College University, Faisalabad · PK

Funding

The authors thank the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University for funding this work through Research Group no. RG 21-09-77 Research Group no. RG 21-09-77
6 · The paper itself

Abstract

Green synthesis is one of the promising pathways for biologically active nanoscale materials. Herein, an eco-friendly synthesis of silver nanoparticles (SNPs) was carried out using an extract of

Indexed as

multi-drug-resistant pathogensphotolytic degradationsilver nanoparticlesTeucrium stocksianum

Identifiers

PMID37110928
PMCPMC10145101
OpenAlexW4365149591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.